The present studies first determined the NIRF contrast from the MMP-14 targeted peptide probes in multiple human GBM orthotopic xenograft models that express MMP-14, as a continuation of our prior work using these probes in a single orthotopic model of GBM 29. Here, MMP14 is linked to glioblastoma.